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ABSTRACT 
The heterodimeric L-type amino acid transporter (LAT) 1/ CD98hc is overexpressed in lung 
cancers with a poor prognosis factor. Factors that contribute to LAT1/CD98hc overexpression 
in lung cells remain however to be determined, but the implication of atmospheric pollution 
can be suspected. The present study was therefore designed to analyze the effects of diesel 
exhaust particle (DEP) extract (DEPe) on LAT1/CD98hc expression in bronchial epithelial 
BEAS-2B cells. Exposure to DEPe up-regulated LAT1 and CD98hc mRNA levels in a 
concentration-dependent manner, with DEPe EC50 values (around 0.2 μg/mL) relevant to 
environmental situations. DEPe concomitantly induced LAT1/CD98hc protein expression and 
LAT1-mediated leucine accumulation in BEAS-2B cells. Inhibition of the aryl hydrocarbon 
receptor (AhR) pathway through the use of a chemical AhR antagonist or the siRNA-
mediated silencing of AhR expression was next found to prevent DEPe-mediated induction of 
LAT1/CD98hc, indicating that this regulation depends on AhR, known to be activated by 
major chemical DEP components like polycyclic aromatic hydrocarbons. DEPe exposure was 
finally shown to induce mRNA expression and activity of matrix metalloproteinase (MMP)-2 
in BEAS-2B cells, in a CD98hc/focal adhesion kinase (FAK)/extracellular regulated kinase 
(ERK) manner, thus suggesting that DEPe-mediated induction of CD98hc triggers activation 
of the integrin/FAK/ERK signaling pathway known to be involved in MMP-2 regulation. 
Taken together, these data demonstrate that exposure to DEPe induces functional 
overexpression of the amino acid transporter LAT1/CD98h in lung cells. Such a regulation 
may participate to pulmonary carcinogenic effects of DEPs, owing to the well-documented 
contribution of LAT1 and CD98hc to cancer development.  
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INTRODUCTION 
L-type amino acid transporter (LAT) 1/CD98hc is a heterodimeric plasma membrane 
protein consisting of a light chain (LAT1, encoded by the SLC7A5 gene) linked to a heavy 
chain (CD98hc, also known as 4F2hc, and encoded by the SLC3A2 gene) by an extracellular 
disulfide bridge (Fotiadis et al., 2013). LAT1 is responsible for L-type sodium-independent 
uptake of large neutral amino acids such as leucine, isoleucine, methionine or tyrosine across 
cell membrane (Kanai et al., 1998). Molecular basis of this transport corresponds to an 
obligatory amino acid exchange with 1:1 stoichiometry (Verrey, 2003); the efflux substrate is 
in parallel handled by a sodium-dependent unidirectional influx system A or N amino acid 
transporter, that appears therefore to be the primary source of the driving force for LAT1-
mediated transport. In addition to neutral amino acids, thyroid hormones as well as a few 
drugs like L-DOPA, alpha-methyldopa, melphalan, and gabapentin are transported by LAT1 
(del Amo et al., 2008; Kinne et al., 2011). With respect to the heavy chain CD98hc, it serves 
as a chaperone for LAT1, allowing to localize and stabilize it at the plasma membrane of 
cells, without transport function (Palacin and Kanai, 2004). CD98hc also plays this role 
towards other amino acid transporters to which it is covalently linked such as LAT2/SLC7A8 
and the L-type sodium-dependent amino acid transporters y+LAT1/SLC7A7 and 
y+LAT2/SLC7A6 (Fotiadis et al., 2013).  
Amino acids transported by LAT1 serve not only for protein synthesis, but also as 
signaling molecules (Taylor, 2014). The essential amino acid leucine is thus a master 
regulator of mammalian target of rapamycin complex 1 (mTORC1) (Nicklin et al., 2009), a 
signaling pathway involved in promotion of cellular growth through phosphorylation of 
substrates that potentiate anabolic processes such as mRNA translation and lipid synthesis, or 
limit catabolic processes such as autophagy (Laplante and Sabatini, 2012). By this way, LAT1 
is thought to favor cancer cell proliferation and metastasis (Fuchs and Bode, 2005; Wang and 
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Holst, 2015). CD98hc also independently promotes cancer development, through its direct 
binding to ?-integrins (mainly β1 but also β3), which is presumed to modulate tumorigenic 
integrin-dependent events such as survival, proliferation, migration and transformation (Feral 
et al., 2005). As an example, CD98hc has been shown to control activity of focal adhesion 
kinase (FAK), an integrin-related signaling way, which in turn may result in modulation of 
the matrix metalloproteinase (MMP)-2 (Santiago-Gomez et al., 2013), strongly implicated in 
cancer progression (Bauvois, 2012).  
Both LAT1 and CD98hc have been shown to be overexpressed in many cancers (Kaira 
et al., 2008). They are notably detected in non-small cell lung cancers, for which they are 
considered as poor prognosis parameters (Imai et al., 2009; Kaira et al., 2010; Fei et al., 
2014). Regulatory factors that may be involved in the induction of their expression in lung 
cells remain however to be characterized. A role for atmospheric pollutants may be suspected, 
notably for diesel exhaust particles (DEPs), which are now recognized as carcinogenic for the 
lung (Vermeulen et al., 2014). Indeed, DEPs, originating from diesel engines and to which 
humans are widely exposed in industrialized and/or urban areas (Gouge et al., 2010), are 
composed of a center core of elemental carbon to which various chemicals, especially 
polycyclic aromatic hydrocarbons (PAHs), are adsorbed (Wichmann, 2007) and such PAHs 
are potent activators of the aryl hydrocarbon receptor (AhR) signaling pathway (Puga et al., 
2009), involved in LAT1 mRNA up-regulation in hepatocytes (Sarkar et al., 1999; Le Vee et 
al., 2010). The present study was therefore designed to determine whether exposure to DEP 
extract (DEPe) can regulate LAT1/CD98hc in human bronchial epithelial BEAS-2B cells. 
Our results indicate that DEPe induces expression of both LAT1 and CD98hc in an AhR-
dependent manner in lung BEAS-2B cells. DEPe is also demonstrated to concomitantly 
increase uptake of leucine and to up-regulate MMP-2 in a CD98hc-dependent manner, thus 
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bringing evidence that DEPe-mediated up-regulation of LAT1/CD98hc has functional 
consequences in lung cells. 
MATERIALS AND METHODS 
Chemicals and reagents 
DEPe used in the study was the Standard Reference Material 1975 (SRM 1975), 
purchased by the National Institute of Standards and Technology (Gaithersburg, MD, USA). 
It corresponds to a dichloromethane extract of filter-collected combustion particulate matter 
from operating forklifts with diesel engines. Some of its chemical components have been 
previously characterized; SRM 1975 notably contains PAHs such as phenanthrene, 
fluoranthene, chrysene, triphenylene, benzo[b]fluoranthene and benzo[ghi]perylene and nitro-
PAHs such as  1-nitropyrene (Hughes et al., 1997). Dichloromethane was evaporated under 
nitrogen and the final residue was dissolved in dimethyl sulfoxide (DMSO) for cell exposure. 
Benzo(a)pyrene, benzo(e)pyrene, benzanthracene, 1-nitropyrene, chrysene, CH-223191, 
actinomycin D, cycloheximide, rapamycin, roscovitine, PF-573228, wortmannin, U0126 and 
2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH) were purchased from Sigma-
Aldrich (St Louis, MO), whereas 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was obtained 
from Cambridge Isotope Laboratories (Cambridge, MA). Hoechst 33342, propidium iodide 
and TRI Reagent were from Life Technologies (Paisley, United Kingdom). L-[4,5-3H] leucine 
(sp. act. 37 MBq/mL) was provided by Perkin-Elmer (Courtaboeuf, France). Other reagents 
were commercial products of the highest purity available. 
 
Cell culture and treatments 
The human lung epithelial cell line BEAS-2B was routinely cultured in F12K medium 
with 2 mM L-glutamine (Gibco, Cergy-Pontoise, France), supplemented with 1 mM Hepes, 
10% (vol/vol) fetal calf serum (Thermo Fisher Scientific, Illkirch, France), 100 IU/mL 
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penicillin and 100 mg/mL streptomycin. Cells were usually seeded at 11 x 103 cells/cm2 and 
treated by DEPe at confluence stage. Chemicals were initially dissolved in DMSO and stored 
frozen as stock solutions until use. Final concentration of solvent in culture media did not 
exceed 0.2% (vol/vol); control cultures received the same dose of DMSO as for their treated 
counterparts. When chemical inhibitors were used, they were added 30 min before DEPe 
treatment.  
 
Cytotoxicity assays 
Cellular apoptosis or necrosis were investigated through cell staining with 10 μg/mL 
Hoechst 33342 and 1 μg/mL propidium iodide for 15 min at 37°C, as previously described 
(Le Vee et al., 2014). Apoptotic cells, i.e., cells with condensed blue chromatin or fragmented 
blue nuclei, and necrotic cells, i.e., cells with red nuclei, were next counted in comparison 
with total cell population using fluorescence microscopy. 
 
RNA isolation and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) 
analysis 
Total RNAs were extracted using the TRI Reagent method, and then reverse 
transcribed into cDNAs using the RT kit from Applied Biosystems (Foster City, CA). qPCR 
assays were next performed using the fluorescent dye SYBR Green methodology and an ABI 
Prism 7300 detector (Applied Biosystems), as previously described (Le Vee et al., 2009). The 
gene specific primers used were: CD98hc sense, CCAGGTTCGGGACATAGAGA, CD98hc 
anti-sense, GAGCCTTGCCTGAGACAAAC, MMP-2 sense 
ATGGAGGCGCTAATGGCCCG, MMP-2 anti-sense 
GTGTTCAGGTATTGCACTGCCAACT, LAT2 sense ACCGAAACAACACCGAAAAG, 
LAT2 anti-sense GATTCCAGAGCCGATGATGT, LAT3/SLC43A1 sense 
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GGACGTGGAAGCTCTGTCTC, LAT3 anti-sense ATGGCAGAAGAGGCGTAAGA, 
LAT4/SLC43A2 sense GACTGGAGGCTGAAGGAGTG, LAT4 anti-sense 
ACGATTGTGTGCAGGATGAA, y+LAT1 sense GCCCTCTACTCTGCCCTCTT, y+LAT1 
anti-sense GTCACAGCCACAGCATCACT, y+LAT2 sense CTCTCCATTGGCATCTCCAT 
and y+LAT2 anti-sense GAGGCCACCAAAACAGGATA. Primers used for cytochrome P-
450 (CYP) 1A1, CYP1B1, LAT1 and 18S detection were exactly as previously reported (Le 
Vee et al., 2010). The specificity of each gene amplification was verified at the end of qPCR 
reactions through analysis of dissociation curves of the PCR products. Amplification curves 
were next analyzed with ABI Prism 7000 SDS software using the comparative cycle threshold 
method. Relative quantification of the steady-state target mRNA levels was calculated after 
normalization of the total amount of cDNA tested to the 18S RNA endogenous reference 
using the 2(-ΔCt) method. Data were routinely expressed as fold-induction factor comparatively 
to mRNA levels found in untreated cells or, alternatively, in arbitrary units relatively to 18S 
RNA as previously reported (Le Vee et al., 2015a). 
 
RNA interference experiments  
Cells were initially seeded at 2.5 x 103 cells/cm2 in 12-well plates. After a 4 days-
culture period, cells were washed with phosphate-buffered saline and media was then replaced 
with opti-MEM (Gibco) containing 8 μL/mL of lipofectamine 2000 (Life Technologies) and 
100 pmol of small-interfering RNA (siRNA). Two duplex of siRNAs targeting AhR (si AhR), 
early growth response 1 (EGR1) (si EGR1) or CD98hc (si CD98hc) mRNAs and one duplex 
used as a negative non-targeting control (si NT) were purchased from Sigma-Aldrich. After 6 
h, this medium was changed by usual medium. Treatment by DEPe was performed after an 
additional 18 h culture-period. BEAS-2B cells transfected by siRNAs failed to exhibit 
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obvious morphological features of toxicity, as demonstrated by light microscopic examination 
of the cultures (data not shown). 
 
Western-blot analysis 
Protein extracts were prepared as previously described (van Grevenynghe et al., 2004; 
Macoch et al., 2015). Protein lysates were then separated on polyacrylamide gel and 
electrophoretically transferred onto Protan® nitrocellulose membranes (Whatman GmbH, 
Dassel, Germany). After blocking with Tris-buffered saline containing 4 % (vol/vol) bovine 
serum albumin and 0.1% (vol/vol) Tween 20 for 30 min at room temperature, membranes 
were incubated overnight at 4°C with primary antibodies against LAT1, CD98hc, EGR1, 
phospho-extracellular regulated kinase (ERK), phospho-FAK (Tyr 397), phospho-FAK (Tyr 
925), phospho-p70S6 kinase (p70S6K), total-p70S6K, phospho-S6, total-S6 (Cell Signaling 
Technology, Danvers, MA), AhR  (Abcam, Cambridge, United Kingdom) or HSC70 (Santa 
Cruz Biotechnology, CA). After washing, membranes were next re-incubated with 
appropriate horseradish peroxidase-conjugated secondary antibodies (Dako, Glostrup, 
Denmark). Immunolabeled proteins were finally visualized by chemiluminescence. Gel 
loading and transfer were checked up by staining membranes with Ponceau red. Densitometry 
with ImageJ 1.40g software (National Institutes of Health, Bethesda, MD) was used for 
quantifying intensities of stained bands.   
 
LAT1-mediated transport assay 
LAT1 activity was measured by determining intracellular accumulation of the 
reference LAT1 substrate leucine in the presence or absence of 1 mM BCH, a well-
documented inhibitor for system L amino acid transporters (Imai et al., 2010). Briefly, cells 
were incubated at 37°C with 0.69 nM L-[4,5-3H] leucine for 5 min in a well-defined sodium-
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free transport medium consisting of 5.3 mM KCl, 1.1 mM KH2PO4, 0.8 mM MgSO4, 1.8 mM 
CaCl2, 11 mM D-glucose, 10 mM HEPES and 136 mM N-methyl glucamine and adjusted to 
pH 7.4, in the absence or presence of 1 mM BCH. After washing in phosphate-buffered 
saline, cells were lysed and intracellular accumulation of leucine was next determined through 
scintillation counting.  
 
Zymographic analysis of MMPs  
Because MMPs can degrade gelatin, zymographic techniques were used to detect 
MMP-2 activity in the supernatant of BEAS-2B treated or not by DEPe as previously reported 
(Manoury et al., 2005). In nonreducing conditions and in the presence of sodium dodecyl 
sulfate, aliquots of cell culture supernatant underwent electrophoresis onto a 4% acrylamide 
stacking gel/ 10% acrylamide separating gel containing 1 mg/mL gelatin. After 
electrophoresis, gels were washed twice with 2.5% (vol/vol) Triton X-100, rinsed with water, 
and incubated overnight at 37°C in 50 mM Tris, 5 mM CaCl2, 2 μM ZnCl2, adjusted to pH 8. 
The gels were next stained with Coomassie Brilliant Blue in a solution of 25% (vol/vol) 
ethanol-10% (vol/vol) acetic acid in water and rinsed in an identical solution. Gelatinase A 
activity due to MMP-2 finally appeared as clear 72 kDa-bands against blue background (Toth 
et al., 2012). Recombinant protein molecular weight markers (10-170 kDa) were used in 
parallel to estimate the molecular weights of the gelatinolytic bands.  
 
Statistical analysis 
Quantitative data were usually expressed as means ± S.E.M of values from at least 
three independent experiments.   Data were statistically analyzed using analysis of variance 
followed by the Tukey’s post-hoc test or using Student’s t test. The criterion of significance 
was p < 0.05. Half maximal effective concentration (EC50) values were determined using 
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GraphPad Prism software (GraphPad Software, La Jolla, CA), through nonlinear regression 
based on the four parameter logistic function. 
RESULTS 
Induction of LAT1/CD98hc expression by DEPe 
Beas-2B cells were first exposed to 5 μg/mL DEPe, which corresponds to a 1.31 
μg/cm2 equivalent DEP dose according to previous conversions of in vitro DEPe/DEP 
concentrations to DEP dose/unit surface area (Li et al., 2003) and is in the range of DEPe 
concentrations usually retained for treating cultured cells (Koike et al., 2002; Schwarze et al., 
2013; Jaguin et al., 2015). Treatment of Beas-2B cells by 5 μg/mL DEPe treatment for 48 h 
failed to trigger toxicity as demonstrated by light phase-contrast microscopic examination of 
cell cultures (data not shown) and evaluation of cell apoptosis or necrosis (Fig. S1). Both 
LAT1 and CD98hc mRNA levels were found to be significantly up-regulated by 5 μg/mL 
DEPe from 8 h exposure (Fig. 1A). Longer treatment (up to 48 h) did not more enhance 
SLC3A2 mRNA expression, that was maximally induced by approximately a 3-fold factor in 
response to DEPe; by contrast, LAT1 mRNA induction factor raised with time exposure, to 
reach a 5.4-fold factor in response to a 48 h exposure to DEPe (Fig. 1A). We next 
demonstrated that the inducing effect of DEPe towards LAT1 and CD98hc mRNA expression 
was concentration-dependent (Fig. 1B), with DEPe EC50 values of 0.25 μg/mL and 0.17 
μg/mL for LAT1 and CD98hc, respectively. 
In contrast to LAT1, other amino acids transporters covalently linked to CD98hc such 
as LAT2, y+LAT1 and y+LAT2 were not induced by a 48-h exposure to DEPe (Fig. 1C).  
Similarly, mRNA levels of the membrane facilitator system L amino acid transporters LAT3 
and LAT4 were not up-regulated by DEPe (Fig. 1C).  
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Western-blotting next indicated that DEPe also induced LAT1 and CD98hc expression 
at the protein level in BEAS-2B cells (Fig. 2A). These inductions were time-dependent and 
were maximal after a 48 h exposure to DEPe, as demonstrated by densitometric analysis of 
the blots (Fig. 2B). 
 
AhR and EGR1 involvement in DEPe-mediated induction of LAT1/CD98hc 
To characterize the molecular mechanisms involved in DEPe-triggered induction of 
LAT1/CD98hc, we first analyzed the effects of the transcription inhibitor actinomycin D and 
of the protein synthesis inhibitor cycloheximide. As shown in Fig. 3, actinomycin D 
prevented both LAT1 and CD98hc up-regulation in response to DEPe, indicating thus that 
active transcription was required for inducing effects of DEPe towards LAT1/CD98hc mRNA 
expression in BEAS-2B cells. By contrast, cycloheximide failed to inhibit LAT1 and CD98hc 
mRNA induction by DEPe (Fig. 3), thus showing that DEPe-mediated up-regulation of 
LAT1/CD98hc did not need de novo protein synthesis. Cycloheximide treatment was in fact 
able to induce by itself CD98hc mRNA levels (Fig. 3), suggesting that an unidentified short-
lived protein likely acts as an endogenous repressor of CD98hc expression. 
Putative AhR involvement in DEPe-mediated up-regulation of LAT1/CD98hc was 
next studied. The AhR reference target genes CYP1A1 and CYP1B1 (Kawajiri and Fujii-
Kuriyama, 2007) were found to be markedly induced by DEPe, as soon as an 8 h exposure to 
the extract (Fig. S2A), thus providing evidence that the AhR signaling way was activated by 
DEPe in BEAS-2B cells. DEPe effects towards CYP1A1 and CYP1B1 mRNA levels were 
concentration-dependent, with DEPe EC50 values of 0.91 μg/mL and 1.15 μg/mL for 
CYP1A1 and CYP1B1, respectively (Fig. S2B). The functionality of the AhR signaling 
cascade in BEAS-2B cells was further confirmed by the fact that several known agonists of 
AhR, such as TCDD and the PAHs benzo(a)pyrene, benzanthacene and chrysene (Machala et 
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al., 2001; Sorg, 2014), induced CYP1A1 mRNA expression in BEAS-2B cells, in a manner 
similar to DEPe, except for chrysene for which the inducing effect was rather weaker (Fig. 4). 
By contrast, benzo(e)pyrene and 1-nitropyrene, that are considered as poor activators of AhR 
(van Grevenynghe et al., 2003; Ovrevik et al., 2010), failed to induce CYP1A1 expression. 
Interestingly, TCDD, benzo(a)pyrene, benzanthracene and chrysene, unlike benzo(e)pyrene 
and 1-nitropyrene, induced mRNA expression of LAT1 and CD98hc (Fig. 4). To more 
directly prove the involvement of AhR in DEPe-mediated regulation of LAT1/CD98hc, the 
effects of the AhR antagonist CH-223191 (Kim et al., 2006) was next studied. This chemical 
inhibited CYP1A1 induction by DEPe; it also significantly decreased LAT1 and CD98hc 
mRNA up-regulation due to DEPe (Fig. 5A). Similarly, transfection of siRNAs against AhR, 
that resulted in a marked reduction of AhR protein expression (Fig. S3A), abolished induction 
of CYP1A1, LAT1 and CD98hc by DEPe (Fig. 5B).  
Various transcription factors can contribute to the AhR signaling pathway, notably 
through direct physical interaction with AhR (Hankinson, 2005). It is the case for EGR1, that 
participates to AhR-mediated regulation of thrombospondin-1 in endothelial cells (Dabir et 
al., 2008). Transfection of siRNAs targeting EGR1 in BEAS-2B cells, that decreased EGR1 
protein expression to 22.9 + 5.6 % of the level found in control cells transfected with non-
targeting SiRNA (Fig. 6A and Fig. S4A), counteracted DEPe-mediated LAT1 and CD98hc 
induction in BEAS-2B cells, but failed to act on CYP1A1 up-regulation (Fig. 6B). In the same 
way, roscovitine, that markedly decreased EGR1 expression in BEAS-2B cells to 28.3 + 7.3 
% of the level found in untreated cells (Fig. 6C and Fig. S4B) through possibly its inhibiting 
effect towards cyclin-dependent kinases (Lee and Kim, 2004), prevented DEPe-triggered up-
regulation of LAT1 and CD98hc, but not that of CYP1A1 (Fig. 6D).   
 
Differential effects of DEPe on LAT1 and mTORC1 activities in BEAS-2B cells 
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 Treatment by DEPe significantly increased uptake of the LAT1 substrate leucine in 
BEAS-2B cells (Fig. 7A). Moreover, this uptake of leucine was similarly inhibited by the 
LAT1 inhibitor BCH in both untreated and DEPe-treated BEAS-2B cells (Fig. 7A), thus 
indicating it was most likely related to LAT1 activity.  
By contrast, DEPe treatment for 24 h or 48 h failed to enhance phosphorylation of the 
reference mTORC1 target p70S6K (Dunlop and Tee, 2009) and phosphorylation of the 
downstream substrate of p70S6K, i.e., the ribosomal protein S6 (Fig. 7B). In this context, it is 
noteworthy that treatment by the mTORC1 inhibitor rapamycin resulted in a marked 
reduction of p70S6K and S6 phosphorylation in BEAS-2B cells either exposed or not to 
DEPe (Fig. 7B), thus likely highlighting a constitutional high activation of the mTORC1 
signaling pathway in these lung cells, regardless of DEPe treatment.   
 
CD98hc-dependent induction of MMP-2 expression by DEPe in BEAS-2B cells   
 In order to determine whether CD98hc up-regulation by DEPe may have functional 
consequences in BEAS-2B cells, we finally analyzed expression of MMP-2, that has been 
previously shown to be a target for the CD98hc/?1-integrin/FAK signaling way (Santiago-
Gomez et al., 2013). As indicated in Fig. 8A, exposure to DEPe induced MMP-2 expression 
in a time-dependent manner, MMP-2 mRNA levels being maximally increased by a 5.7-fold 
factor after a 48 h exposure. Gelatinase activity due to MMP-2 was concomitantly increased 
by DEPe, as demonstrated by zymographic analysis (Fig. 8B). MMP-2 mRNA up-regulation 
by DEPe was next found to be abolished by cycloheximide (Fig. 8C), thus demonstrating that 
it required de novo protein synthesis. Abolishing DEPe-mediated CD98hc induction through 
efficiently knocking-down CD98hc expression at mRNA (Fig. 8D) and protein (Fig. S3B) 
level using siRNA transfection further prevented induction of MMP-2 by DEPe, but not that 
of CYP1A1 (Fig. 8D). Taken together, these data are consistent with the assertion that de 
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novo enhanced synthesis of CD98hc in response to DEPe is specifically required for MMP-2 
up-regulation.  
 The putative contribution of FAK to MMP-2 regulation by DEPe was characterized 
using the chemical FAK inhibitor PF-573228 (Slack-Davis et al., 2007). As shown in Fig. S5, 
PF-573228 effectively inhibited FAK phosphorylation on Tyr (397) and on Tyr (925) in 
BEAS-2B cells exposed or not to DEPe for 24 h; this DEPe treatment, fully efficient for 
inducing CD98hc protein expression (Fig. 2), otherwise failed to enhance basal 
phosphorylated FAK levels in BEAS-2B cells (Fig. S5). PF-573228 prevented MMP-2 up-
regulation by DEPe, without impairing those of CD98hc and CYP1A1 (Fig. 9A).  
 Participation to DEPe-mediated MMP-2 induction of signaling ways such as the 
mitogen-activated protein kinase ERK and the phosphatidylinositol-3 kinase (PI3K)/Akt, that 
are presumed to act downstream of FAK (Sawai et al., 2005; Santiago-Gomez et al., 2013), 
was finally studied. The ERK inhibitor U0126, which effectively blocked ERK 
phosphorylation in BEAS-2B cells either exposed or not to DEPe (Fig. S5), prevented MMP-
2 up-regulation by DEPe, without inhibiting those of CD98hc and CYP1A1 (Fig. 9B). 
Phosphorylated ERK levels did not however vary in a major way in BEAS-2B cells in 
response to a 24 h treatment by DEPe (Fig. S5). U0126 by itself was otherwise found to 
induce mRNA expression of CD98hc and CYP1A1 (Fig. 9B), which likely reflects the fact 
that U0126 can activate AhR (Andrieux et al., 2004). In contrast to U0126, the PI3K/Akt 
inhibitor wortmannin did not block DEPe-triggered induction of MMP-2 (data not shown). 
 
DISCUSSION 
The present study indicates that exposure to DEPe increases expression of the 
heterodimeric amino acid transporter LAT1/CD98hc in lung epithelial cells. Indeed, treatment 
of lung BEAS-2B cells by DEPe coordinately up-regulated each of the two subunits of the 
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transporter, i.e., the catalytic LAT1 and the chaperone CD98hc, at both mRNA and protein 
levels in BEAS-2B cells. This up-regulation of LAT1/CD98hc was otherwise not a part of a 
putative general/unspecific alteration of system L amino acid transporter expression by DEPe 
exposure because LAT3 and LAT4, as well as other CD98hc-linked amino acid transporters 
such as y+LAT1 and y+LAT2, were not induced by DEPe. Environmental atmospheric 
pollutants like DEPe can therefore be unambiguously added to the list of factors specifically  
targeting LAT1, comprising estrogens (Soulez and Parker, 2001), nutrients (Drummond et al., 
2010) or hypoxic stimuli (Elorza et al., 2012). Interestingly, in addition to LAT1/CD98hc, the 
efflux drug transporters P-glycoprotein/ABCB1 and breast cancer resistance protein/ABCG2 
are induced in response to DEPs/DEPe (Hartz et al., 2008; Le Vee et al., 2015b). Moreover, 
PAHs, that represent major chemical components of DEPe, also regulate expression of the 
drug transporter multidrug resistance protein 4/ABCC4 (Xu et al., 2010). Taken together, 
these data indicate that membrane transporters constitute targets for DEPs or DEPs-related 
chemicals. This conclusion is additionally fully supported by the fact that activity of some 
drug transporters such as multidrug resistance protein 2/ABCC2 and the organic anion 
transporting polypeptides 1B1/SLCO1B1 and 1B3/SLCO1B3 can be markedly and directly 
impaired by DEPe (Le Vee et al., 2015b).  
The molecular mechanism involved in LAT1/CD98hc induction by DEPe most likely 
involves AhR. Indeed, several arguments are in favor of this conclusion: (i) DEPe effectively 
activated the AhR signaling pathway in BEAS-2B cells, as demonstrated by the up-regulation 
of the AhR reference target genes CYP1A1 and CYP1B1, (ii) the EC50 values for DEPe-
mediated up-regulation of LAT1 and CD98hc mRNA levels are in the range of those for 
DEPe-related induction of CYP1A1 and CYP1B1, suggesting that these regulations share the 
same way of signaling, (iii) DEPe-related PAHs that are known to activate the AhR, such as 
benzo(a)pyrene or benzanthracene, also increased expression of LAT1 and CD98hc, in 
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contrast to PAHs not, or only poorly, activating AhR, such as benzo(e)pyrene and 1-
nitropyrene, (iv) the reference AhR ligand TCDD induced expression of LAT1, in agreement 
with previous results (Sarkar et al., 1999; Le Vee et al., 2010), and also that of CD98hc and 
(v) abolition of the AhR signaling cascade using chemical AhR antagonist or silencing of 
AhR expression prevented DEPe-mediated regulation of LAT1/CD98hc. Because 
experiments with actinomycin D and cycloheximide have indicated that DEPe-mediated 
induction of LAT1/CD98hc mRNA required active transcription, but not protein synthesis, a 
direct transcriptional regulation by AhR of LAT1/SLC7A5 and CD98hc/SLC3A2 genes 
through its cognate DNA motif, dioxin-response element (DRE), may be hypothesized, as 
well-documented for AhR-dependent regulation of reference AhR target genes like CYP1A1 
and CYP1B1 genes (Kawajiri and Fujii-Kuriyama, 2007). The fact that several core DRE 
(GCGTG) sequences were found in the promoters of LAT1/SLC7A5 and CD98hc/SLC3A2 
genes (data not shown) is consistent with this hypothesis. Further studies, including promoter 
deletion analysis, would be however required to determine whether these DRE sequences are 
functional. Importantly, the requirement of AhR activation for DEPe-mediated induction of 
LAT1/CD98hc indicates that DEPe-contained chemicals implicated in this regulation are 
necessary AhR agonists. In this context, PAHs, that correspond to main chemicals adsorbed 
on DEPs (Wichmann, 2007), can be highly suspected. It is however noteworthy that DEPs 
contain various different PAHs and the induction of LAT1/CD98hc by DEPe may therefore 
reflect the exposure to a complex mixture of PAHs rather than that to a single PAH.  
Various cofactors of AhR have been described, including EGR1 (Dabir et al., 2008). 
Repression of this transcription factor through siRNA transfection or roscovitine treatment 
was found to prevent DEPe-mediated induction of LAT1/CD98hc, thus suggesting that EGR1 
acts as a required coactivator of AhR for the regulation of the amino acid transporter subunits 
by DEPe in BEAS-2B cells. By contrast, AhR-mediated regulation of CYP1A1 appears to be 
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EGR1-independent. The exact way by which EGR1 may contribute to AhR-dependent 
induction of LAT1/CD98hc in response to DEPe remains to be determined. EGR1 may be 
postulated to physically form a complex with AhR, which may in turn favor the binding of 
AhR/EGR1 to the promoter of the responsive genes, as already demonstrated for the AhR-
dependent regulation of thrombospondin (Dabir et al., 2008). Further studies are likely 
required to investigate this hypothesis. 
LAT1 induction by DEPe has functional consequences in BEAS-2B cells in term of 
amino acid transport, as demonstrated by the increased BCH-inhibitable uptake of leucine in 
DEPe-exposed BEAS-2B cells when compared to untreated counterparts. Up-regulation of 
LAT1 activity has been associated with enhanced mTORC1 activity in various cell models 
(Nicklin et al., 2009; Sinclair et al., 2013). By contrast, LAT1-mediated enhanced 
accumulation of leucine failed to induce mTORC1 activity in DEPe-exposed BEAS-2B cells. 
The reason for such a lack of up-regulation is unclear, but could be linked to the high 
constitutional activity of mTORC1 in BEAS-2B cells, regardless of DEPe treatment.  
MMP-2 was found to be up-regulated at both mRNA levels and activity level in 
DEPe-exposed BEAS-2B cells. MMP-2 mRNA up-regulation by DEPe required protein 
synthesis; it was also dependent on AhR-dependent CD98hc induction by DEPe and on FAK 
activity. MMP-2 induction may therefore be considered as a secondary response to DEPe 
exposure, likely driven by the CD98hc/?1-integrin/FAK signaling cascade, that has 
previously been shown to participate to MMP-2 expression in HeLa cells (Santiago-Gomez et 
al., 2013). Besides FAK, the MAPK ERK, that commonly acts downstream the former kinase 
(Saleem et al., 2009), is also involved in MMP-2 induction by DEPe, because the ERK 
inhibitor U0126 fully prevented it; by contrast, a role for the PI3K/Akt pathway has to be 
discarded, because the PI3K/Akt inhibitor wortmannin had no effect. It is however 
noteworthy that we failed to clearly detect increased FAK or ERK phosphorylation  in 
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response to a 24-h exposure to DEPe in BEAS-2B cells, whereas MMP-2 mRNA was already 
induced by a 3.2-fold factor for this treatment time. In this context, it is noteworthy that early 
and transient inductions of ERK and FAK activities  commonly occur in response to various 
types of stimuli (Li et al., 1997; Rosado et al., 2000), including exposure to DEPs-related 
PAHs (Lecureur et al., 2005; Castillo-Sanchez et al., 2013). This may be consistent with the 
hypothesis that DEPe only transiently induced FAK and ERK activity in BEAS-2B cells, as 
soon as a sufficient level of DEPe-mediated CD98hc induction was reached. The time of 
exposure to DEPe required for reaching this initial relevant induction of CD98hc can be 
hypothesized to be approximately in the range of 8-24 h according to data from time-course 
analysis of CD98hc protein regulation by DEPe (Fig. 2). We however failed  to detect FAK or 
ERK activation in response to DEPe exposure for 4 h, 6 h, 8 h, 9 h, 10 h, 11 h, 12 h or 16 h 
(data not shown), which supports the hypothesis of a transient and fleeting activation of these 
kinases in response to DEPe. The exact DEPe treatment time required for getting minimal 
level of DEPe-induced CD98hc protein sufficient to activate the ?-integrin/FAK/ERK 
pathway may be consequently likely uneasy to precisely determine. For summarizing (Fig. 
S6), DEPe is likely to first induce CD98hc expression in an AhR-dependent manner and then 
CD98hc, up-regulated by DEPe, may secondly induce MMP2 expression via FAK and ERK 
activation. DEPe-mediated up-regulation of CD98hc has therefore biological consequences, 
i.e., MMP-2 up-regulation. 
The relevance of our in vitro findings to in vivo exposure to atmospheric DEPs 
constitutes probably a key-point that has to be clarified. In this context, it is noteworthy that 
the DEPe EC50 values up-regulating LAT1/CD98hc, that are around 0.2 μg/mL, correspond to 
approximately 0.04 μg/cm2 equivalent DEP dose according to previous conversions of in vitro 
DEPe/DEP dose to DEP dose/unit surface area (Li et al., 2003). Importantly, such exposure 
levels are thought to be achieved in respiratory tracts for subjects exposed to DEPs-containing 
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atmospheres (Li et al., 2003), thus underlining the fact that our in vitro exposure conditions 
may be close to environmental exposure situations. Humans exposed to atmospheric DEPs 
may therefore be hypothesized to exhibit increased level of LAT1/CD98hc expression in lung 
cells. This may in turn contribute to the toxicity of DEPs, notably to their carcinogenic 
effects, owing to the well-established implication of LAT1 and CD98hc in cancer promotion 
and progression, and, by this way, this may participate to the well-established overexpression 
of LAT1/CD98hc in lung cancers (Kaira et al., 2009). Carcinogenesis is however well-known 
to be a multistep process (Barrett, 1993). Therefore, it could be speculated that LAT1/CD98hc 
induction in response to DEPe may contribute to initiation of lung cancer and that 
LAT1/CD98hc overexpression becomes constitutive in later phases of carcinogenesis, 
through unknown mechanisms. 
In summary, exposure to DEPe, used at concentrations relevant to environmental 
situations, was demonstrated to induce functional expression of the heterodimeric amino acid 
transporter LAT1/CD98hc in lung epithelial BEAS-2B cells in an AhR-dependent manner. 
Such an up-regulation may contribute to the toxicity of atmospheric DEPs, notably to their 
carcinogenic effects.   
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LEGENDS TO FIGURES 
Fig. 1. Induction of LAT1/CD98hc mRNA expression by DEPe. 
BEAS-2B cells were either untreated or exposed to (A) 5 μg/mL DEPe for various lengths of 
time (from 8 h to 48 h), (B) to various DEPe concentrations (from 0.01 to 10 μg/mL) for 24 h 
or (C) to 5 μg/mL DEPe for 24 h. (A, B) LAT1, CD98hc and (C) other amino acid transporter 
subunit mRNA expressions were next determined by RT-qPCR. Data are expressed (A, B) as 
fold induction factor comparatively to mRNA levels found in untreated cells or (C) in 
arbitrary units, as described in Materials and Methods; they are the means + SEM of three 
independent assays.  (A, C) *, p<0.05 when compared to untreated cells.  
 
Fig. 2. Induction of LAT1/CD98hc protein expression by DEPe. 
BEAS-2B cells were either untreated or exposed to 5 μg/mL DEPe for various lengths of time 
(from 8 h to 48 h). LAT1 and CD98hc contents were then determined by Western-blot 
analysis; HSC70 content was analyzed in parallel as a gel loading control. (A) A 
representative blot is shown for LAT1 and CD98hc. (B) LAT1- and CD98hc-related stained 
bands were quantified by densitometric analysis and expressed relatively to expression level 
found in untreated cells, arbitrarily set at the value of 100%, after normalization to HSC70 
content. Values are the means ± SEM of three independent assays. *, p < 0.05 when compared 
to untreated cells. 
 
Fig. 3 Effects of actinomycin D and cycloheximide on DEPe-mediated up-regulation of 
LAT1/CD98hc mRNA expression.  
BEAS-2B cells were either untreated or exposed to 5 μg/mL DEPe, 1 μg/mL actinomycin D 
(actino D) or 5 μg/mL cycloheximide (CHX) or co-exposed to DEPe/actinomycin D or 
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DEPe/cycloheximide for 8 h. LAT1 and CD98hc mRNA expressions were next determined by 
RT-qPCR. Data are expressed as fold induction factor comparatively to mRNA levels found in 
untreated cells and are the means + SEM of three independent assays.  *, p<0.05 when 
compared to untreated cells.  
 
Fig. 4. Effects of various environmental aryl hydrocarbons on LAT1/CD98hc mRNA 
expression. BEAS-2B cells were either untreated or exposed to 5 μg/mL DEPe, 10 μM 
benzo(a)pyrene (B(a)P), 10 μM benzanthracene (BZA), 10 μM benzo(e)pyrene (B(e)P), 10 
μM 1-nitropyrene (1-NP), 10 μM chrysene or 10 nM TCDD. CYP1A1, LAT1 and CD98hc 
mRNA expressions were next determined by RT-qPCR. Data are expressed as fold induction 
factor comparatively to mRNA levels found in untreated cells and are the means + SEM of at 
least three independent assays.  *, p<0.05 when compared to untreated cells.  
 
Fig. 5. Effects of AhR inhibition or silencing on DEPe-mediated LAT1/CD98hc mRNA 
expression. 
(A) BEAS-2B cells were either untreated or exposed to 5 μg/mL DEPe, in the absence or 
presence of the AhR antagonist CH-223191, used at 3 μM, for 8 h. (B) BEAS-2B cells, 
transfected by siRNAs against AhR (si AhR) or by control non-targeting siRNAs  (si NT), 
were either untreated or exposed to 5 μg/mL DEPe for 8 h. (A, B) LAT1, CD98hc and 
CYP1A1 mRNA expressions were next determined by RT-qPCR. Data are expressed as fold-
induction factor comparatively to mRNA levels found in untreated cells and are the means + 
SEM of at least three independent assays.  *, p<0.05. 
 
Fig. 6. Effects of EGR1 down-regulation on DEPe-mediated LAT1/CD98hc mRNA 
expression. 
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(A) BEAS-2B cells were transfected by siRNAs against EGR1 (si EGR1) or by control non-
targeting siRNAs (si NT). EGR1 protein content in cell lysates was then determined by 
Western-blot analysis; data shown are representative of three independent experiments. (B) 
siRNA-transfected BEAS-2B cells were either untreated or exposed to 5 μg/mL DEPe for 8 h. 
LAT1, CD98hc and CYP1A1 mRNA expressions were next determined by RT-qPCR. Data 
are expressed as fold-induction factor comparatively to mRNA levels found in untreated cells 
and are the means + SEM of at least three independent assays.  (C) BEAS-2B cells were 
either untreated or exposed to 10 μM roscovitine for 2 h. EGR1 protein content in nuclei 
extracts was then determined by Western-blot analysis; data shown are representative of three 
independent experiments. (D) BEAS-2B cells, previously exposed or not to 10 μM 
roscovitine for 8 h, were additionally either untreated or treated by 5 μg/mL DEPe for 8 h. 
LAT1, CD98hc and CYP1A1 mRNA expressions were next determined by RT-qPCR. Data 
are expressed as fold-induction factor comparatively to mRNA levels found in untreated cells 
and are the means + SEM of at least three independent assays. (B, D)  *, p<0.05. NS, not 
statistically significant. 
 
Fig. 7. Effects of DEPe on LAT1 and mTORC1 activity. 
(A) BEAS-2B cells, either untreated or treated by 5 μg/mL DEPe for 48 h, were incubated 
with 0.69 nM L-[4,5-3H] leucine for 5 min in the absence or presence of 1 mM BCH. 
Intracellular accumulation of leucine was then determined by scintillation counting. Data are 
expressed as % of intracellular uptake of leucine in control untreated cells and are the means 
+ SEM of three independent assays. *, p<0.05. (B) BEAS-2B cells were either untreated or 
treated by 5 μg/mL DEPe in the absence or presence of 100 nM rapamycin (rapa) for 24 or 48 
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h. Phospho-p70S6K, total-p70S6K, phospho-S6 and total-S6 contents were then determined 
by Western-blot analysis; data shown are representative of three independent experiments.  
 
Fig. 8. CD98hc-dependent induction of MMP-2 expression by DEPe. 
(A, B) BEAS-2B cells were either untreated or exposed to 5 μg/mL DEPe for various lengths 
of time (from 8 h to 48 h). (A) MMP-2 mRNA expression was next determined by RT-qPCR. 
Data are expressed as fold induction factor comparatively to mRNA levels found in untreated 
cells and are the means + SEM of three independent assays. (B) Gelatinase activity of MMP-2 
was analyzed as described in Materials and Methods. Data shown are representative of three 
independent experiments. (C) BEAS-2B cells were either untreated or exposed to 5 μg/mL 
DEPe for 24 h in the absence or presence of 5 μg/mL cycloheximide (CHX). MMP-2 mRNA 
expression was next determined by RT-qPCR. Data are expressed as fold induction factor 
comparatively to mRNA levels found in untreated cells and are the means + SEM of three 
independent assays.  *, p<0.05. (D) BEAS-2B cells, transfected by siRNAs against CD98hc 
(si CD98hc) or by control non-targeting siRNAs  (si NT), were either untreated or exposed to 
5 μg/mL DEPe for 24 h. CD98hc, MMP-2 and CYP1A1 mRNA expressions were next 
determined by RT-qPCR. Data are expressed as fold induction factor comparatively to mRNA 
levels found in untreated cells and are the means + SEM of at least three independent assays.  
*, p<0.05. NS, not statistically significant. 
 
Fig. 9. Effects of FAK and ERK inhibition on DEPe-mediated up-regulation of MMP-2. 
BEAS-2B cells were either untreated or exposed to 5 μg/mL DEPe for 24 h, in the absence or 
presence of (A) the FAK inhibitor PF-573228, used at 1 μM, or (B) the ERK inhibitor U0126, 
used at 5 μM. MMP-2, CD98hc and CYP1A1 mRNA expressions were next determined by 
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RT-qPCR. Data are expressed as fold induction factor comparatively to mRNA levels found in 
untreated cells and are the means + SEM of at least three independent assays.  *, p<0.05. NS, 
not statistically significant. 
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Highlights 
 
- The amino acid transporter LAT1/CD98hc is up-regulated in DEPe-treated lung cells 
- The aryl hydrocarbon receptor is involved in DEPe-triggered induction of 
LAT1/CD98hc  
- DEPe enhances LAT1-mediated accumulation of leucine in lung cells 
- DEPe increases MMP-2 expression and activity in a CD98hc/FAK/ERK-dependent 
manner  
